SCHEMBL20914053

SCHEMBL20914053

COc1cccc2oc(-c3c(C(=O)NC(CO)C(C)C)[nH]c4c(-c5ccccc5)c(C(F)(F)F)nn4c3=O)nc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4B Q07343 4/20 0.34
▸ MKNK1 Q9BUB5 2/20 0.34
▸ PDE2A O00408 2/20 0.33
▸ ELANE P08246 2/20 0.33
▸ F2RL3 Q96RI0 2/20 0.32
▸ ARF6 P62330 1/20 0.32
▸ CYP3A4 P08684 1/20 0.31
▸ HTR3A P46098 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ SRC P12931 1/20 0.31
▸ TOP2A P11388 1/20 0.31
▸ GUCY1B2 O75343 1/20 0.31
▸ GUCY1A2 P33402 1/20 0.31
▸ GUCY1A1 Q02108 1/20 0.31
▸ GUCY1B1 Q02153 1/20 0.31
▸ GPR139 Q6DWJ6 1/20 0.31
▸ POLB P06746 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20914051 1.00 PDE4B (0.34) PDE4BMKNK1PDE2AELANEF2RL3
SCHEMBL20913950 0.94 PDE4B (0.35) PDE4BMKNK1PDE2AELANEF2RL3
SCHEMBL20913948 0.94 PDE4B (0.35) PDE4BMKNK1PDE2AELANEF2RL3
SCHEMBL20914008 0.88 TAAR1 (0.33) PDE4BPDE2AF2RL3ARF6CYP3A4
SCHEMBL20914000 0.87 F2RL3 (0.33) PDE4BF2RL3ARF6CYP3A4HTR3A
SCHEMBL20819040 0.87 TNKS (0.35) F2RL3ARF6TOP2APOLBMEN1
SCHEMBL20818972 0.87 NPC1 (0.35) MKNK1F2RL3CYP3A4HTR3AKCNH2
SCHEMBL20914027 0.86 PTGER1 (0.36) PDE4BPDE2AF2RL3ARF6CYP3A4
SCHEMBL20913994 0.86 POLB (0.37) F2RL3ARF6TOP2APOLBMEN1
SCHEMBL20837044 0.86 F2RL3 (0.33) PDE4BPDE2AF2RL3ARF6CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
CN-111212839-A Pyrazolopyrimidinone compounds and uses thereof 艾杜罗生物科技公司 2020-05-29 — — CN disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof NLRP3, NLRP1, P2RX7 PDE4B 190/4885MKNK1 1171/4885PDE2A 291/4885
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF NLRP3, NLRP1, P2RX7 PDE4B 190/4885MKNK1 1171/4885PDE2A 291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback